[smelendez]

Probably medication fraud.

They mention heightened scrutiny around controlled substances (with amphetamines for ADHD as an example) on the FAQ. https://help.headway.co/hc/en-us/articles/29673299878676-Doc...

The risk is that a drug dealer or addict pays people to use their identities and possibly insurance info, pretends to be them and to have ADHD in telehealth sessions, and stockpiles Adderall.

[olyjohn]

How many people would you need to stack up in therapy just to get enough Adderall to sell to make money? One person is only going to be able to get a 30 day supply at a time. Most people taking it for recreation are taking much higher doses than prescribed. I don't think that a drug dealer is going to be organized enough to do hour long sessions every week for 30 different people and not get noticed.

[smelendez]

The ADHD patients aren’t necessarily the ones doing weekly talk therapy. They’re meeting occasionally for a quick chat with a psychiatrist.

I agree, if you’re just doing talk therapy it seems overkill. But they may have concerns about emergencies, where a patient is in crisis and you realize you don’t actually know who they are.

And insurance fraud: Alice has health insurance, her friend Betty does not but needs therapy, so she signs up under Alice’s name (“oh, I actually go by Betty.”)

In general, I don’t think it’s that outlandish that the company wants to know definitively who its patients are and be able to demonstrate it does, but hopefully they can come up with more options for verification.

[siva7]

Well, that doesn't scale to be worth the risk, and should be immidiately obvious to any dealer with an iq higher than room temperature.